FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely to endocrinology, and concerns treating diabetes mellitus. That is ensured by administering a pharmaceutical composition containing activated-potentiated forms of insulin receptor and endothelial NO-synthase antibodies.
EFFECT: invention provides the effective treatment of diabetes mellitus by the synergetic effect of the ingredients of the composition on the pathogenic mechanisms of the disease that are reducing the insulin resistance and the blood glucose level.
20 cl, 6 dwg, 5 ex
